Anzeige
Mehr »
Login
Dienstag, 20.10.2020 Börsentäglich über 12.000 News von 649 internationalen Medien
Der SCHWEDEN-HAMMER! Vieles deutet auf ein gewaltiges Vorkommen! Fliegt jetzt der Deckel bei den Aktien weg?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 856273 ISIN: JP3942400007 Ticker-Symbol: YPH 
Tradegate
20.10.20
11:54 Uhr
12,045 Euro
+0,130
+1,09 %
Branche
Pharma
Aktienmarkt
NIKKEI-225
1-Jahres-Chart
ASTELLAS PHARMA INC Chart 1 Jahr
5-Tage-Chart
ASTELLAS PHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
11,78512,02517:03
11,79012,02017:14

Aktuelle News zur ASTELLAS PHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:33Astellas Pharma: FDA Grants Fast Track Designation For ASP0367/MA-0211111TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) announced that the FDA has granted Fast Track designation for the development of ASP0367/MA-0211 as a potential treatment for primary...
► Artikel lesen
ASTELLAS PHARMA Aktie jetzt für 0€ handeln
FrFiercePharmaAsia-COVID-19 drug manufacturing; Roche's China slowdown; Astellas' Iota buy24
FrAstellas to acquire iota Biosciences following R&D partnership2
DoAfter R&D tryout, Astellas opts to acquire bioelectronics maker Iota Biosciences in $304M deal1
DoAstellas to merge with iota: Astellas Pharma, through a US subsidiary, has signed off on a deal to buy California-headquartered ...-
DoAstellas wagers $425M-plus to buy a shot at hatching a 'neural dust' breakthrough in bioelectronics-
DoAstellas to acquire iota Bio1
13.10.Seagen, Astellas report positive results from PADCEV phase 2 trial in advanced urothelial cancer7
12.10.Seagen, Astellas eye earlier Padcev use in bladder cancer with long-lasting phase 2 results7
12.10.News briefing: Gilead reveals more filgotinib data; Seagen and Astellas report new cohort for Padcev19
12.10.Astellas/Seagen's Pacdev Shows Durable Response In Phase 2 Urothelial Cancer Study279TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) and Seagen Inc. (SGEN) announced results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial saying that...
► Artikel lesen
12.10.Seagen/Astellas's Pacdev shows durable response in mid-stage urothelial cancer study2
23.09.Ort des Tages: Astellas Pharma Headquarter Österreich (Leya Hempel)331Ort des Tages: Astellas Pharma Headquarter Österreich. Wenn Organe wie Nieren, Leber oder Herz transplantiert werden, besteht immer die Gefahr, dass der Körper das neue Organ abstößt. Astellas bietet...
► Artikel lesen
20.09.ESMO: AstraZeneca, Merck's Lynparza boosts prostate cancer survival by 31% over J&J, Pfizer-Astellas rivals27
18.09.Astellas, Seattle Genetics' Padcev bladder cancer trial stops early with 30% death risk reduction9
18.09.Seattle Genetics' Astellas-partnered ADC nails confirmatory PhIII in urothelial cancer2
18.09.Seattle Genetics, Astellas Say Phase 3 Trial Of PADCEV Meets Primary Endpoint830TOKYO (dpa-AFX) - Biotechnology company Seattle Genetics, Inc. (SGEN) and Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY, ALPMY) announced Friday that a phase 3 trial of PADCEV...
► Artikel lesen
18.09.Seattle Genetics/Astellas Pharma's PADCEV shows survival benefit in previously treated urothelial cancer5
26.08.Astellas Pharma Inc. -- Moody's announces completion of a periodic review of ratings of Astellas Pharma Inc.4
25.08.Technavio Research: Analysis on Impact of COVID-19- Global Clostridium Difficile Treatment Market 2020-2024 | Evolving Opportunities With Astellas Pharma Inc. and AstraZeneca Plc | Technavio155The global clostridium difficile treatment market size is expected to grow by USD 159.87 million as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due...
► Artikel lesen
Seite:  Weiter >>
79 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1